Laxmi Organic Industries Limited has confirmed the successful and disciplined utilization of its Qualified Institutions Placement (QIP) proceeds for the quarter ending March 31, 2026. With a total issue size of INR 2,591.21 million, the company maintains full alignment with the stated objectives of the issue, reporting no deviations in fund application. The capital has been directed toward strategic innovation and manufacturing expansion projects vital for long-term growth.
Strategic Deployment of Capital
As of the quarter ended March 31, 2026, Laxmi Organic Industries has effectively utilized a total of INR 2,483.34 million from its QIP proceeds. The primary focus of these funds remains the capital expenditure requirements for two flagship projects: the new Innovation Centre at Mahape and the manufacturing facility expansion at Dahej. Both initiatives are instrumental in scaling the company’s R&D efforts and manufacturing capacity to meet growing market demand.
Project Status and Updates
The innovation center in Mahape has reached completion and is currently operational. Despite a six-month delay in the initial timeline due to structural workspace constraints, the facility has now been fully inaugurated. Meanwhile, the expansion of the manufacturing facility at village Jolve and Vadadla (Dahej) remains ongoing. Following a formal reallocation of funds approved by shareholders in December 2025, the budget for the Dahej project was revised to INR 1,729.24 million to ensure the successful execution of this key growth asset.
Financial Oversight
The monitoring agency, India Ratings & Research, has verified that all expenditures are in line with the disclosed objectives of the issue. The company has demonstrated sound financial management, with a remaining unutilized balance of INR 107.87 million. These funds are currently deployed in low-risk liquid instruments—specifically the ABSL Arbitrage Fund—ensuring that capital remains protected while waiting to be fully deployed in the ongoing manufacturing expansion.
Source: BSE
